Advancements in the Understanding of Paclitaxel Metabolism in Tissue Culture
Journal:
Current Pharmaceutical Biotechnology
Volume:
8
Page:
219-236
Author(s):
Kham Vongpaseuth and Susan C. Roberts
Prophylactic Vaccine Strategies and the Potential of Therapeutic Vaccines Against Herpes Simplex Virus
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
1975-1988
Author(s):
Michael W. Ferenczy
Fibroblast Growth Factors/Fibroblast Growth Factor Receptors as Targets for the Development of Anti-Angiogenesis Strategies
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2025-2044
Author(s):
M. Rusnati and M. Presta
Targeted Multifunctional Lipid-Based Nanocarriers for Image-Guided Drug Delivery
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
7
Page:
425-440
Author(s):
Gerben A. Koning and Gerard C. Krijger
An Update in the Development of HIV Entry Inhibitors
Journal:
Current Topics in Medicinal Chemistry
Volume:
7
Page:
1273-1289
Author(s):
Stefano Rusconi, Andrea Scozzafava, Antonio Mastrolorenzo and Claudiu T. Supuran
Oncogenic Properties of HIV-Tat in Colorectal Cancer Cells
Journal:
Current HIV Research
Volume:
5
Page:
403-409
Author(s):
Duy Huynh, Elizabeth Vincan, Theo Mantamadiotis, Damian Purcell, Chee-Kai Chan and Robert Ramsay
Matrix Metalloproteinases: New Routes to the Use of MT1-MMP As A Therapeutic Target in Angiogenesis-Related Disease
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
1787-1802
Author(s):
A. G. Arroyo, L. Genis, P. Gonzalo, S. Matias-Roman, A. Pollan and B. G. Galvez
Real-Time PCR: Revolutionizing Detection and Expression Analysis of Genes
Journal:
Current Genomics
Volume:
8
Page:
234-251
Author(s):
S.A. Deepak, K.R. Kottapalli, R. Rakwal, G. Oros, K.S. Rangappa, H. Iwahashi, Y. Masuo and G.K. Agrawal
Mechanisms to Inhibit Matrix Metalloproteinase Activity: Where are we in the Development of Clinically Relevant Inhibitors?
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
135-142
Author(s):
Christian A. Corbitt, Jing Lin and Merry L. Lindsey
Integrin αvβ3 Antagonists for Anti-Angiogenic Cancer Treatment
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
143-158
Author(s):
Andrew R. Hsu, Anand Veeravagu, Weibo Cai, Lewis C. Hou, Victor Tse and Xiaoyuan Chen